Latest News

The CE-IVDR-certified test is designed to detect three diabetes-associated autoantibodies (AAbs) that can indicate an increased risk of developing T1D.

Anaconda is targeting the large vessel occlusion stroke market, where mechanical thrombectomy is used to remove blood clots from blocked cerebral arteries.

T cell engagers are designed to bring a patient’s T cells into contact with cancer cells, enabling the immune cells to attack the tumour.

The companies said the partnership will support the introduction of MetMark into US laboratories using the XpressGT platform.

Under the proposal, timely pathogen sharing would support research and development while facilitating access to vaccines, medicines, diagnostics and other health products.

WHO bases its recommendations on surveillance data collected through the Global Influenza Surveillance and Response System (GISRS), supported by collaborating centres and essential regulatory laboratories.

ALMA and Malaria No More UK estimate that a 30% reduction in malaria financing could result in 146 million additional cases, almost 400,000 additional deaths and US$37 billion in lost economic output by 2030.

The DIGIT platform is designed as an open and interoperable system that brings campaign planning, management and monitoring into a single interface.

Earendil, a biotechnology company operating in the US and China, will identify and develop bispecific antibody programmes based on target combinations agreed with Genentech.

The collaboration comes as pharmaceutical developers explore alternative delivery routes for biologic medicines, which can present formulation and administration challenges because of their molecular size and complexity.